CleanSpark shares to outperform bitcoin in 2025, says H.C. Wainwright
H.C. Wainwright analyst Mike Colonnese says CleanSpark (CLSK) reported solid fiscal Q4 results and reiterated its prior calendar year-end 2024 ...
Janux Therapeutics price target raised to $70 from $63 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on Janux Therapeutics (JANX) to $70 from $63 and keeps a Buy ...
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage ...
Splash Beverage price target lowered to 50c from $1 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares ...
bovnews23h
Hut 8 Corp (HUT) Stock Settles at $28.37: What’s Contributing to This Price Point?
On Friday, Hut 8 Corp (HUT) stock saw a decline, ending the day at $28.37 which represents a decrease of $-0.08 or -0.28% from the prior close of $28.45. The stock opened at $28.45 and touched a low ...
bovnews1d
Why Did H.C. Wainwright Give Energy Fuels Inc (UUUU) Stock Buy Rating?
On Friday, Energy Fuels Inc (UUUU) stock saw a modest uptick, ending the day at $7.29 which represents a slight increase of $0.49 or 7.21% from the prior close of $6.8. The stock opened at $7.1 and ...
Why Purple Biotech (PPBT) Stock Is Getting Hammered
Purple Biotech shares are trading lower by 28% during Tuesday's session. The company announced a $2.8 million offering.
Investing4d
H.C. Wainwright reiterates Neutral on Agenus stock, focus on bot/bal in colorectal cancer
On Friday, H.C. Wainwright maintained a Neutral rating and a $7.00 price target on Agenus Inc . (NASDAQ:AGEN), a biotechnology company currently valued at approximately $82 million. According to ...
ETF Daily News2d
electroCore, Inc. Enters into At The Market Offering Agreement with H.C. Wainwright & Co., LLC
The Company clarified that they are not obligated to sell any Shares under this agreement. H.C. Wainwright & Co., LLC will act to sell the Shares based on electroCore’s instructions and within the ...
Nasdaq4d
Splash Beverage price target lowered to 50c from $1 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares following the Q3 report. The business stalled until new funding ...
Nasdaq4d
CollPlant initial breast implant data ‘encouraging,’ says H.C. Wainwright
H.C. Wainwright maintains a Buy rating and 12-month price target of $11 on CollPlant (CLGN) shares after the company reported Q3 results and provided a corporate update on November 27. The firm ...
Investing4d
H.C. Wainwright reiterates Buy on IceCure Medical stock, FDA decision on ProSense expected soon
as recommended by H.C. Wainwright. According to InvestingPro analysis, the stock appears undervalued at its current trading level. The reaffirmation came after IceCure Medical announced its third ...